To compare computed tomography (CT) images and bronchoscopic findings of local tumor recurrence at the bronchial stump site in post-operative non-small cell lung cancer (NSCLC) patients. Materials and Methods: A retrospective study was conducted to review the CT images of 9 lung cancer cases that recurred at the bronchial stump site on 576 resected primary non-small cell lung cancers over a 9-year period. The CT images of the bronchial stump site recurrence were classified as: bronchial wall thickening, nodular or endobronchial polypoid lesion, multiplicity, and enhancement patterns. We classified the bronchoscopic findings based on the revised classification by the Japan Lung Cancer Society. Results: The histologic types of the 9 cases of lung cancer that recurred, included 7 squamous cell carcinomas, 1 adenocarcinoma, and 1 adenoid cystic carcinoma. The CT findings included bronchial wall thickening with nodules (n = 6) and endobronchial polypoid nodules (n = 3) with heterogeneous enhancement. The CT findings were further classified as nodular infiltrating type (n = 5), polypoid type (n = 3) and superficial infiltrating type (n = 1) on bronchoscopy. Conclusion: Both a bronchoscopy and CT can be used as a complementary or alternative tool in evaluating bronchial stump site recurrences.
The recurrence of non-small cell lung cancer (NSCLC) is frequent after such treatments as a curative resection, chemotherapy, radiation therapy or multimodal therapy. In patients with stage I disease confirmed at surgery, the overall reported recurrence rates range from 27 to 39% (1) (2) (3) . Among them, 10 to 20% of cases show locoregional recurrences, while 60 to 70% of cases show distant recurrences (1, 4, 5) . Locoregional recurrence means recurrent disease in the ipsilateral hilar or mediastinal lymph nodes as well as in the surgical margin, including the bronchial stump, pleura, and chest wall (6, 7) .
In the past days, most cases of the recurring lung cancers were found in advanced stages because they had been diagnosed using a chest X-ray and bronchoscopy. Nowadays, technical advances in both chest computed tomography (CT) and bronchoscopy have been helpful in diagnosing the locoregionally recurring lung cancers in their earlier stages (7) (8) (9) (10) . Previous studies have suggested a relationship between bronchoscopic findings and chest X-ray findings of bronchial stump recurrence (8) . To our knowledge, however, there has been no study that has suggested a relationship between the CT findings and bronchoscopic findings of bronchial stump recurrence.
Thus, the aim of our study was to present the CT images individually with the corresponding bronchoscopic findings of local tumor recurrence at the bronchial stump site, based on recently the reported bronchoscopic classification.
Materials and Methods
No specific approval was deemed necessary by our institutional review board for this retrospective study. Informed consent was obtained from all patients before performing follow-up chest CT scans.
Study Design
From January 1995 to December 2004, 3872 patients were diagnosed with lung cancer at our institution. Of these, 576 patients with under stage IIIA NSCLC underwent radical surgery. The stages of all patients were reported in accordance with the New International Staging System for Lung Cancer. Staging definitions for the T (primary tumor), N (regional lymph nodes), and M (distant metastasis) components were in accordance with the International Staging System for Lung Cancer (11, 12) . In this study, bronchial stump cancer recurrence was defined as recurrent disease occurring in the surgical margin of bronchus only. We did not include regional lymph node, chest wall, or pleural disease recurrence. A total of 12 cases (2.08%) had recurrent disease at the bronchial stump sites. In all cases, the resection margin was microscopically negative for tumor cells at the time of surgery. Three of the twelve cases were excluded from the study because their CT images were unavailable on our image data base. Therefore, our study included 9 patients (8 men, 1 woman, mean age: 66 years, age range: 56 to 74 years). During the followup periods, the patients underwent a CT or bronchoscopy as scheduled at the three month, six month and one year mark after surgery. If any abnormal findings were identified on the chest X-rays or symptoms, a CT or bronchoscopy was performed. Any identified recurrent disease was confirmed histopathologically by a bronchoscopic biopsy.
We retrospectively acquired individual information about the histopathologic types of lung cancers, operation types, postoperative pathologic staging, time interval between operation and recurrence, and bronchoscopic findings from medical records.
CT scans were obtained using a single-detector helical CT scanner (Tomoscan SR-7000, Philips Medical Systems, Best, Netherlands), a 4-slice CT scanner (LightSpeed, GE Medical Systems, Milwaukee, Wis.), or a 16-slice CT scanner (LightSpeed Pro 16, GE Medical Systems, Milwaukee, Wis.). The CT protocol was consisted of a 5.0-(single-detector helical CT scanner), 2.5-(multi-slice CT scanners) mm collimation, pitch of 1.0 (Tomoscan SR-7000, LightSpeed Pro 16), 1.5 (LightSpeed) at 120 kVp, 180-200 mAs, 40 seconds after the administration of 100-120 mL (3 mL/sec via the intravenous route) of contrast medium (Ultravist, Schering, Seoul, Korea), and covering the lung apices to both adrenal glands.
Chest CT Image Evaluation
All CT images were reviewed as a consensus interpretation by two radiologists who are specialists in chest imaging. The images were photographed at the mediastinal (width, 350 H; level, 50 H) and lung (width, 1600 H; level, -600 H) window settings. The CT scans were assessed for the presence and distribution of the recognized features of bronchial stump site recurrence, including bronchial wall thickening, nodular and endobronchial polypoid lesion, multiplicity, and enhancement patterns. Bronchial wall thickening was defined as the difference between the pathologic site and the normal site, which shows smooth tapering. A nodular infiltrating type was defined as the round protrusion, from the bronchial stump to the lumen. The polypoid type was defined as the lobular protrusion with a single stalk, from the bronchus to the lumen.
Bronchoscopy Evaluation
Two physicians and pulmonary specialists reviewed all the lesions on the bronchoscopy as a consensus interpretation, and classified them based on the bronchoscopic findings of the revised classification by the Japan Lung Cancer Society ( Fig. 1) (13) . The bronchoscopic findings were divided into mucosal invasion type and submucosal invasion type. The mucosal invasion type means tumor growth mainly in the mucosal epithelium, and is subclassified as follows: superficial infiltrating type (thickened type), nodular infiltrating type, and polypoid type. The superficial infiltrating types of recurrences is characterized as mucosal changes, such as redness or a whitish patch at the mucosa, without a contour abnormality. The nodular infiltrating type is characterized as mucosal change with the round mucosal protrusion from the bronchus to the lumen. The polypoid type is characterized as the lobular mucosal protrusion with a single stalk, from the bronchus to the lumen. Submucosal types show tumor growth in layers deeper than the lamina propria and are classified into the superficial type, infiltrating type, and extramural type.
Results
Out of 576 patients, 12 (2.08%) had bronchial stump recurrences. The histologic types of 9 cases of recurred cancers for which the CT images were available, included 7 squamous cell carcinomas, 1 adenocarcinoma, and 1 adenoid cystic carcinoma. The surgical resections involved lobectomy (n = 2), bilobectomy (n = 1), and pneumonectomy (n = 6). The post-operative pathologic stages of the tumors included stage IB (n = 3), IIB (n = 4), and IIIA (n = 2) at the time of surgery. The interval between the time of operation and recurrence ranged from 17 to 72 months (mean 32 ± 9 months). The relationships between age, sex, histopathologic type, operation type, TNM staging, the interval between operation and recurrence, bronchoscopic findings, and CT findings for individual patients are described in Table 1 .
The CT scans revealed that all recurrences were in the form of soft tissues occupying the space around stump site. Further, the CT scans demonstrated nodular lesions with heterogeneous enhancement in all cases. Three of the cases had multiple recurrence sites at the time of recurrence, while 2 cases had nodular infiltrating types and 1 case had a polypoid type.
The bronchoscopic findings found that all of the lesions were classified as mucosal invasion types (no submucosal invasion type were observed). The bronchoscopic findings showed 5 nodular infiltrating types, 3 polypoid types, and 1 superficial infiltrating type of re- currences.
The 6 cases of superficial infiltrating and nodular type recurrences demonstrated nodular infiltrations around the bronchial stumps and into the bronchial wall. The 3 remaining polypoid type recurrences demonstrated lobular infiltration to the lumen on the CT scan. Grossly, these bronchoscopic and CT image findings corresponded well with each other.
Discussion
Radical resection is considered as an adequate treatment for providing survival benefits for early stages of NSCLC, especially for the patients without metastasis into the lymph nodes. However, even after radical resection, recurrences of lung cancer are not unusual events, occurring in 27 to 39% of patients (1-3). There may be tumor recurrence at the bronchial stump, even when the margin of the resected specimen is negative for cancer and the resected margin is sufficiently distant from the tumor. One of the reason for this is even a visual examination of the stump site following a curative resection does not reveal any tumor, but pathologists report the presence of microscopic, residual tumor tissue at the bronchial resection margin in approximately 4-5% of all lung resections (14) .
In this study, the recurrences at the bronchial stump were seen in 2.08% (12 cases) of all cases of resected lung cancers, and this result is similar to the stump recurrence rates of previous studies (7, 8) . However, the cases described by Jang et al. (7) were mostly submucosal type (7) , whereas all of the recurrences in the current study were of mucosal type on bronchoscopic findings (5 nodular infiltrating types, 3 polypoid types, and 1 superficial infiltrating type). This difference may be due to the fact that we targeted patients who had recurrences at the bronchial stump sites and excluded those who had recurrences at the lymph nodes. Another possibility for the discrepancy is that we used the revised classification by the Japan Lung Cancer Society for the classification of bronchoscopic findings. All the nodular infiltrative type recurrences were from squamous cell carcinomas, which was consistent with the results of other studies and demonstrated heterogeneous enhancing nodules on the CT scan (8) . Three out of the 9 cases had endobronchial polypoid nodules. One of them was from a squamous cell carcinoma, and the other polypoid type recurrences were from adenocarcinoma and adenoid cystic carcinoma. Jang et al. (7) reported the bronchial stump recurrences from squamous cell carcinomas only (7) . However, the study of Miura et al. that preceded the aforementioned study of Jang et al. reported recurrences from various types of lung cancer (8) . It is clear that lung cancer recurrences at bronchial A bronchoscopy is a sufficient tool to evaluating mucosal changes and contour changes in the bronchial lumen. However, there is a tendency to underestimate the infiltrating degree and perilesional conditions. On bronchoscopy, there was one superficial infiltrating type recurrence detected in this study. But in same case, on the CT findings, there was a heterogeneous enhancing nodular soft tissue lesion at the bronchial stump site. On the other hand, the bronchoscopy is thought to be more sensitive than a chest CT when evaluating early local recurrences that do not show bronchial wall thickening or nodular infiltration. In summary, when a bronchoscopy reveals the possibility of local infiltration, a cross-sectional examination, such as a CT, should be performed in order to know how much the cancer has advanced.
However, when testing for early recurrent cancer that is not easily visible on a chest CT, the bronchoscopy is more advantageous. In that sense, the two examinations complement each other.
Five cases of the nodular infiltrative type showed nodular lesions originating from a post-operative bronchial stump site on CT findings (Fig. 2) . Both the superficial infiltrative type and nodular infiltrative type of recurrences appeared as heterogeneous enhancing nodules that showed an imprint and direct invasion of the adjacent bronchus or trachea. In contrast, the three polypoid type recurrences were found to be endobronchial polypoid nodules. The recurrences of the polypoid type seem to originate from the superficial layer, while some invade into the bronchial lumen (case 7), and others invade into both the bronchial lumen and in- to the bronchial wall (case 8, 9) (Fig. 3) . Considering this result, we propose that the recurrence of the polypoid type may originate at a more superficial layer of the bronchus, compared to the other types, such as superficial or nodular infiltrative types. According to the previous study, residual tumor cells can infiltrate the entire bronchial wall or can be confined to a specific part of the bronchial wall and the involved part can be classified as mucosal, such as an in situ or invasive carcinoma (14) .
There are several limitations to our study: first, sample size was small because of the low incidence of bronchial stump recurrence after primary radical surgery. Accordingly, the ability of our data to represent all the recurrences at the bronchial stump site is limited, and we did not perform any statistical analysis to determine any correlations between bronchoscopic findings, CT findings, and other factors. Secondly, the study was unable to identify the origin of the recurrent tumors pathologically, because additional operations were not performed in some patients. So, we could not pinpoint the bronchial layer that gave rise to the tumor. We expect it to be proven that the polypoid type recurrences originate from the mucosal layers, while the superficial infiltrative type and nodular infiltrative type recurrences originate from extra-mucosal layer. Another concern is that we used 3 different CT scanners with different protocols, and, as a result, we may not have obtained consistent result.
In conclusion, the correlation with bronchoscopic and CT findings is possible in verifying the presence of a recurrence at the bronchial stump site. In other words, both a bronchoscopy and CT can be used as complementary or alternative tools in evaluating bronchial stump site recurrences. Also, when referring to chest CT findings for polypoid type and nodular infiltrative type recurrences, the origin of the tumor may lead to different types of recurrence. In effect, the CT findings for recurrent lung cancer at the bronchial stump are nodules with heterogeneous enhancement.
